Abstract

AN OVERVIEW OF PARKINSON'S DISEASE TREATMENT AND IT’S STRATEGIES

Soujanya Munegowda*, Alfiya, Priyanka Anjinappa

Abstract

Parkinson's disease (PD) is a neurological condition that typically manifests between the age of 55 and 65. The entire quality of life is significantly impacted by the increasing development of both motor and non-motor symptoms. Although there isn't a cure, a number of therapies have been created to assist control Parkinson's disease symptoms. The discipline of Parkinson's disease (PD) management is expanding and focuses on both novel and improved therapeutic approaches. Physicians can now address patient-specific issues as they emerge in addition to the primary motor symptoms of Parkinson's disease (PD) thanks to pharmaceutical, surgical and therapy interventions. But the therapeutic approach to this condition should incorporate both pharmacological and nonpharmacological strategies. Therefore, in order to improve these treatments and consequently, the patient‘s quality of life, further research into the biology of the condition is required. The established and novel options for treating Parkinson's disease (PD) that can offer patient-specific care and lessen the negative effects of standard therapies are covered in this review.

Keywords: Parkinson's disease, Parkinson's treatment, substantia nigra, basal ganglia, Lewy bodies, a- synuclein, dopamine, levodopa.